Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant609 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05986331 | Clinical Study of the Efficacy and Safety of BCD-201 and Keytruda in Subjects With Advanced Melanoma | unknown | Phase 3 | 366 | BiocadINDUSTRY | 1 | Sep 21, 2023 | clinicaltrials |
| NCT05783882 | Prolgolimab 250 mg Q3W in Patients With Unresectable or Metastatic Melanoma(FLAT) | unknown | Phase 3 | 114 | BiocadINDUSTRY | 1 | Mar 24, 2023 | clinicaltrials |
| NCT01088737 |
| Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna |
| unknown |
| Phase 2 / Phase 3 |
| 60 |
| Medical University of GrazOTHER |
| 1 |
| Aug 13, 2019 |
| clinicaltrials |
| NCT03435302 | HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma | unknown | Phase 3 | 204 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 19, 2018 | clinicaltrials |
| NCT02962947 | MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients | unknown | Phase 2 / Phase 3 | 546 | Azienda Sanitaria di FirenzeOTHER | 0 | Nov 15, 2016 | clinicaltrials |
| NCT00477906 | M-Vax + Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma | unknown | Phase 3 | 387 | AVAX TechnologiesINDUSTRY | 0 | Dec 3, 2015 | clinicaltrials |
| NCT01729663 | Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients | unknown | Phase 2 / Phase 3 | 108 | Laboratorio Pablo Cassara S.R.L.INDUSTRY | 1 | Sep 2, 2015 | clinicaltrials |
| NCT00006249 | Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma | unknown | Phase 3 | 1,258 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 18 | Feb 10, 2015 | clinicaltrials |
| NCT00002767 | Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma | unknown | Phase 3 | 300 | GlaxoSmithKlineINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00039234 | Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver | unknown | Phase 3 | — | Maxim PharmaceuticalsINDUSTRY | 4 | Dec 18, 2013 | clinicaltrials |
| NCT00002455 | Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma | unknown | Phase 3 | — | Centro Oncologico de ExcelenciaOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00002763 | High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma | unknown | Phase 3 | 1,000 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 21 | Nov 16, 2011 | clinicaltrials |
| NCT00811200 | Treatment Of Radiation Retinopathy Trial(TORR) | unknown | Phase 2 / Phase 3 | 220 | Leiden University Medical CenterOTHER | 0 | Jul 2, 2009 | clinicaltrials |
| NCT00005052 | Vaccine Therapy in Treating Patients With Primary Stage II Melanoma | unknown | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 18 | Feb 9, 2009 | clinicaltrials |
| NCT00779714 | Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC(ChemoSensMM) | unknown | Phase 3 | 360 | University of WuerzburgOTHER | 1 | Oct 24, 2008 | clinicaltrials |
| NCT00226408 | Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon | unknown | Phase 3 | 600 | Dermatologic Cooperative Oncology GroupOTHER | 1 | Jun 21, 2006 | clinicaltrials |
| NCT00052130 | Vaccine Therapy for Patients With Stage III Melanoma | unknown | Phase 3 | 1,118 | CancerVax CorporationINDUSTRY | 13 | Jun 24, 2005 | clinicaltrials |
| NCT00052156 | Vaccine Therapy for Patients With Stage IV Melanoma | unknown | Phase 3 | 670 | CancerVax CorporationINDUSTRY | 13 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Sep 21, 2023source: clinicaltrials